These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25063148)

  • 1. IGF-1 release kinetics from chitosan microparticles fabricated using environmentally benign conditions.
    Mantripragada VP; Jayasuriya AC
    Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():506-16. PubMed ID: 25063148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injectable chitosan microparticles incorporating bone morphogenetic protein-7 for bone tissue regeneration.
    Mantripragada VP; Jayasuriya AC
    J Biomed Mater Res A; 2014 Dec; 102(12):4276-89. PubMed ID: 24497318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microencapsulation of mechano growth factor E peptide for sustained delivery and bioactivity maintenance.
    Niu X; Chen P; Jia X; Wang L; Li P; Yang L; Wang Y; Fan Y
    Int J Pharm; 2014 Jul; 469(1):214-21. PubMed ID: 24768406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation.
    Kim S; Kang Y; Krueger CA; Sen M; Holcomb JB; Chen D; Wenke JC; Yang Y
    Acta Biomater; 2012 May; 8(5):1768-77. PubMed ID: 22293583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid biomineralization of chitosan microparticles to apply in bone regeneration.
    Jayasuriya AC; Kibbe S
    J Mater Sci Mater Med; 2010 Feb; 21(2):393-8. PubMed ID: 19756963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of chitosan microparticles intended for controlled drug delivery.
    Ko JA; Park HJ; Hwang SJ; Park JB; Lee JS
    Int J Pharm; 2002 Dec; 249(1-2):165-74. PubMed ID: 12433445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan/TPP microparticles obtained by microemulsion method applied in controlled release of heparin.
    Martins AF; de Oliveira DM; Pereira AG; Rubira AF; Muniz EC
    Int J Biol Macromol; 2012 Dec; 51(5):1127-33. PubMed ID: 22975304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of microparticle protein delivery systems based on calcium alginate.
    Yu CY; Jia LH; Cheng SX; Zhang XZ; Zhuo RX
    J Microencapsul; 2010; 27(2):171-7. PubMed ID: 19538029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionically cross-linked chitosan microspheres for controlled release of bioactive nerve growth factor.
    Zeng W; Huang J; Hu X; Xiao W; Rong M; Yuan Z; Luo Z
    Int J Pharm; 2011 Dec; 421(2):283-90. PubMed ID: 22001532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tartrate/tripolyphosphate as co-crosslinker for water soluble chitosan used in protein antigens encapsulation.
    Srivastava G; Walke S; Dhavale D; Gade W; Doshi J; Kumar R; Ravetkar S; Doshi P
    Int J Biol Macromol; 2016 Oct; 91():381-93. PubMed ID: 27246374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan microparticle preparation for controlled drug release by response surface methodology.
    Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
    J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Formulation and Process Parameters on Chitosan Microparticles Prepared by an Emulsion Crosslinking Technique.
    Rodriguez LB; Avalos A; Chiaia N; Nadarajah A
    AAPS PharmSciTech; 2017 May; 18(4):1084-1094. PubMed ID: 27995463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles.
    Lin CC; Fu CH
    Drug Deliv; 2009 Jul; 16(5):274-9. PubMed ID: 19538009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation.
    Barakat NS; Almurshedi AS
    J Pharm Pharmacol; 2011 Feb; 63(2):169-78. PubMed ID: 21235580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of vitamin C encapsulated tripolyphosphate-chitosan microspheres as affected by chitosan molecular weight.
    Desai KG; Liu C; Park HJ
    J Microencapsul; 2006 Feb; 23(1):79-90. PubMed ID: 16830979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of pH-sensitive sodium alginate/chitosan microparticles containing the antituberculosis drug rifampicin.
    Lacerda L; Parize AL; Fávere V; Laranjeira MC; Stulzer HK
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():161-7. PubMed ID: 24863212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of microparticles with gelatin and chitosan.
    Prata AS; Grosso CR
    Carbohydr Polym; 2015 Feb; 116():292-9. PubMed ID: 25458303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of manufacturing parameters on the characteristics of vitamin C encapsulated tripolyphosphate-chitosan microspheres prepared by spray-drying.
    Desai KG; Park HJ
    J Microencapsul; 2006 Feb; 23(1):91-103. PubMed ID: 16830980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxymethyl β-cyclodextrin grafted carboxymethyl chitosan hydrogel-based microparticles for oral insulin delivery.
    Yang Y; Liu Y; Chen S; Cheong KL; Teng B
    Carbohydr Polym; 2020 Oct; 246():116617. PubMed ID: 32747257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.